NCT00607724View on ClinicalTrials.gov

GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

68

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

GDC-0449

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

lead

Genentech, Inc.

INDUSTRY